- athenaheath, Inc. in its $5.7 billion sale to Veritas Capital and Evergreen Coast Capital (an affiliate of Elliott Management Corporation) and planned combination with Virence Health.
- Atos S.E. in its $3.57 billion acquisition of Syntel, Inc.
- Avista Healthcare Public Acquisition Corp. in its acquisition of Organogenesis Inc.
- Ceridian LLC, THL and Fidelity National Financial in the $3.45 billion sale of Comdata Inc. to FleetCor Technologies Inc.
- DIRECTV in its $67.1 billion transaction with AT&T, its acquisition of Liberty Media’s Entertainment Group following its split-off from Liberty Media, and in a variety of financing arrangements.
- The Dow Chemical Company in its $130 billion all-stock merger of equals with E. I. du Pont de Nemours and Company.
- Fidelity National Financial (FNF) in a series of transactions that brought about the tax-free distribution of its interest in Black Knight Financial Services, Inc. (n/k/a Black Knight, Inc.) to owners of FNF Group, following which Black Knight became an independent, publicly traded company; in its redemption of all tracking stock shares of Fidelity National Financial Ventures (FNFV) in exchange for shares of common stock of Cannae Holdings, Inc., following which Cannae became an independent, publicly traded company, and FNF ceased to have a tracking stock structure; in its $2.9 billion acquisition of Lender Processing Services (n/k/a Black Knight, Inc.) and Black Knight’s subsequent $507 million IPO; its acquisition of J. Alexander Corporation; and in a series of transactions bringing about the tax-free distribution of FNF’s ~51% interest in Remy International, Inc. to holders of FNFV tracking stock.
- First Data Corporation in its $760 million acquisition of BluePay, Inc.; its $750 million acquisition via cash tender offer of CardConnect Corp.; and its acquisition of Acculynk.
- General Electric Company in its strategic plan to sell most of GE Capital’s assets, including several related multi-billion dispositions; and in a variety of financing arrangements.
- General Electric Company and Synchrony Financial in GE’s $20.4 billion offer to exchange Synchrony common stock for GE common stock, completing the separation of Synchrony from GE.
- General Electric Company in its $3.4 billion sale of GE Water to SUEZ.
- General Electric Company in its $2.6 billion sale of GE Industrial Solutions.
- Gores Holdings II, a SPAC sponsored by an affiliate of The Gores Group, in its transaction with Verra Mobility Corporation, with an initial enterprise value of approximately $2.4 billion.
- The J.M. Smucker Company in its acquisition of the Folgers coffee business following its split-off from P&G.
- Leucadia National Corporation in its increased investment in HomeFed Corporation and in its $3.7 billion merger with Jefferies Group.
- Medicis Pharmaceutical Corporation in its $2.6 billion sale to Valeant Pharmaceuticals International (n/k/a Bausch Health Companies).
- Sanofi in its $20.1 billion acquisition of Genzyme Corporation; $11.6 billion acquisition of Bioverativ Inc.; and its up to $750 million acquisition of Protein Sciences Corporation.
- Synchrony Financial in its approximately $2.8 billion IPO and related $3.6 billion debt offering, and in its $5.8 billion acquisition of U.S. consumer receivables from PayPal Holdings, Inc., and in connection with its acquisition of approximately $1 billion of participation interests in receivables held with investors and financial institutions.
- Vonage in its acquisitions of iCore Networks, Nexmo, Simple Signal, Vocalocity and Telesphere Networks.
Mr. Neubort is recognized as a “Next Generation Lawyer” for US Taxes: Non-Contentious by Legal 500 US, was named a 2014 Tax “Rising Star” by Law360, and has been named a “New York Metro Rising Star” for Tax by Super Lawyers since 2012.
Mr. Neubort graduated, cum laude, from New York University School of Law and joined the Firm in September of 2002. Mr. Neubort is a member of the Tax Section of the New York State Bar Association.